Esketamine Applications in Postoperative Management

Summary

Esketamine, the S-enantiomer of ketamine, has emerged as a versatile agent in the management of postoperative pain and mood disturbances. Its pharmacological profile combines potent analgesia with rapid antidepressant effects, mediated primarily through antagonism of N-methyl-D-aspartate (NMDA) receptors and downstream modulation of neurotrophic pathways. In perioperative settings, esketamine is administered via single bolus, continuous infusion or as an adjuvant in patient-controlled analgesia to reduce opioid requirements, improve pain scores and attenuate surgical stress responses. Beyond analgesia, low-dose protocols target early postoperative depression, anxiety and inflammatory sequelae, offering accelerated mobilisation and enhanced functional recovery. Clinicians worldwide are refining dosing strategies to balance efficacy with safety, optimising haemodynamic stability and minimising psychotomimetic effects. As part of multimodal analgesia regimens, esketamine is increasingly recognised for its capacity to improve both somatic and psychological outcomes, underlining its global significance in enhancing recovery after surgery.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Esketamine Applications in Postoperative Management publication trend

The graph below shows the total number of articles in esketamine applications in postoperative management across all publications each year (not limited to Nature Index journals).

Technical terms

Esketamine: The S-enantiomer of ketamine with higher affinity for NMDA receptors, used for analgesia and rapid antidepressant effects.

NMDA receptor antagonist: A compound that inhibits N-methyl-D-aspartate receptors, disrupting excitatory neurotransmission to alleviate pain and modulate mood.

Patient-controlled intravenous analgesia (PCIA): A delivery system that allows patients to self-administer predetermined doses of analgesic agents through an intravenous pump.

Edinburgh Postnatal Depression Scale (EPDS): A validated screening questionnaire for detecting depressive symptoms in the postnatal period.

Subanesthetic dose: A dose below the threshold required to induce full anaesthesia, employed to provide analgesia or sedation with minimal loss of consciousness.

References

  1. Effects of perioperative use of esketamine on postpartum depression risk in patients undergoing cesarean section: A randomized controlled trial. Journal of Affective Disorders (2023).
  2. S-ketamine as an adjuvant in patient-controlled intravenous analgesia for preventing postpartum depression: a randomized controlled trial. BMC Anesthesiology (2022).
  3. Effect of subanesthetic dose of esketamine on postoperative rehabilitation in elderly patients undergoing hip arthroplasty. Journal of Orthopaedic Surgery and Research (2023).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.